Nicole La Brosse Halozyme Therapeutics, Inc. (HALO) insider trading activity

HALO Quotes by TradingView

Nicole La Brosse is SVP, CHIEF FINANCIAL OFFICER of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 31,900 shares of HALO, which is worth approximately $1.8 Million. The most recent transaction as insider was on Feb 12, 2023, when has been sold 1,389 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.9K
0% 3M change
106.07% 12M change
Total Value Held $1.8 Million

Nicole LaBrosse Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 12 2023
BUY
Exercise of conversion of derivative security
-
1,389 Added 17.51%
6,545 Common Stock
Feb 10 2023
SELL
Payment of exercise price or tax liability
$68,096 $48.92 p/Share
1,392 Reduced 21.26%
5,156 Common Stock
Feb 10 2023
BUY
Exercise of conversion of derivative security
-
2,503 Added 27.65%
6,548 Common Stock
Nov 15 2022
SELL
Open market or private sale
$268,750 $53.75 p/Share
5,000 Reduced 55.28%
4,045 Common Stock
Feb 15 2022
SELL
Payment of exercise price or tax liability
$14,908 $34.43 p/Share
433 Reduced 4.57%
9,045 Common Stock
Feb 15 2022
BUY
Exercise of conversion of derivative security
-
1,255 Added 11.69%
9,478 Common Stock
Feb 14 2022
SELL
Payment of exercise price or tax liability
$14,364 $33.64 p/Share
427 Reduced 4.94%
8,223 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
-
1,256 Added 12.68%
8,650 Common Stock
Feb 12 2022
SELL
Payment of exercise price or tax liability
$17,305 $34.2 p/Share
506 Reduced 6.41%
7,394 Common Stock
Feb 12 2022
BUY
Exercise of conversion of derivative security
-
1,389 Added 14.95%
7,900 Common Stock
Feb 10 2022
SELL
Payment of exercise price or tax liability
$35,813 $34.94 p/Share
1,025 Reduced 13.6%
6,511 Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
-
2,503 Added 24.93%
7,536 Common Stock
NL

Nicole La Brosse

SVP, CHIEF FINANCIAL OFFICER
San Diego, CA

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HALO